Bloom Burton Analyst Recommendations & Stock Picks

Name: Community Performance Rating
Item: Bloom Burton
Rating: 2.7
Author: MarketBeat

→ Don’t Miss Out on the AI Gold Rush That’s Just Getting Started (From Banyan Hill Publishing) (Ad)

This page lists the most recent publicly-reported stock recommendations and ratings issued by analysts at Bloom Burton. These ratings and price targets were collected from public media reports and are believed to be accurate, but cannot be verified with 100% certainty. MarketBeat and its parent company are in no way affiliated with or endorsed by Bloom Burton.

Company	Current Price	Rating Date	Action	Brokerage	Analyst	Rating	Price Target	Impact on Price	Details
RPTX Repare Therapeutics	$3.36 +3.1%	4/19/2024	Upgraded by	Bloom Burton	Analyst D. Martin	Accumulate -> Buy		Low	View details for Bloom Burton rating of Repare Therapeutics (NASDAQ:RPTX) on 4/19/2024
FUSN Fusion Pharmaceuticals	$21.42 +0.5%	3/20/2024	Downgraded by	Bloom Burton	Analyst D. Martin	Buy -> Hold		Low	View details for Bloom Burton rating of Fusion Pharmaceuticals (NASDAQ:FUSN) on 3/20/2024
RPTX Repare Therapeutics	$3.36 +3.1%	2/13/2024	Downgraded by	Bloom Burton	Analyst D. Martin	Buy -> Accumulate		Low	View details for Bloom Burton rating of Repare Therapeutics (NASDAQ:RPTX) on 2/13/2024
FUSN Fusion Pharmaceuticals	$21.42 +0.5%	1/5/2024	Reiterated by	Bloom Burton	Analyst D. Martin	Buy		Low	View details for Bloom Burton rating of Fusion Pharmaceuticals (NASDAQ:FUSN) on 1/5/2024
MBX Microbix Biosystems	C$0.34 -1.5%	1/4/2024	Reiterated by	Bloom Burton	Analyst D. Martin	Buy		N/A	View details for Bloom Burton rating of Microbix Biosystems (TSE:MBX) on 1/4/2024
ABCL AbCellera Biologics	$3.97 -1.0%	11/3/2023	Reiterated by	Bloom Burton	Analyst D. Martin	Buy		Low	View details for Bloom Burton rating of AbCellera Biologics (NASDAQ:ABCL) on 11/3/2023
Get the Latest News and Ratings for Your Stocks Enter your email address below to receive the latest headlines and analysts' recommendations for your stocks with our free daily email newsletter.
MDP Medexus Pharmaceuticals	C$1.65 +1.9%	6/26/2023	Upgraded by	Bloom Burton	Analyst D. Martin	Hold -> Buy		N/A	View details for Bloom Burton rating of Medexus Pharmaceuticals (TSE:MDP) on 6/26/2023
OPS Opsens	C$2.90	3/28/2023	Reiterated by	Bloom Burton	Analyst D. Martin	Buy		N/A	View details for Bloom Burton rating of Opsens (TSE:OPS) on 3/28/2023
RX BioSyent	C$8.40	3/23/2023	Reiterated by	Bloom Burton	Analyst D. Martin	Accumulate		N/A	View details for Bloom Burton rating of BioSyent (CVE:RX) on 3/23/2023
DOC CloudMD Software & Services	C$0.09	11/16/2022	Upgraded by	Bloom Burton	Analyst P. Pandurangan	Hold -> Accumulate		N/A	View details for Bloom Burton rating of CloudMD Software & Services (CVE:DOC) on 11/16/2022
DOC CloudMD Software & Services	C$0.09	8/24/2022	Downgraded by	Bloom Burton	Analyst P. Pandurangan	Buy -> Hold		N/A	View details for Bloom Burton rating of CloudMD Software & Services (CVE:DOC) on 8/24/2022
MDNA Medicenna Therapeutics	C$1.55 +1.3%	8/16/2022	Target Lowered by	Bloom Burton	-	Buy	C$9.00	N/A	View details for Bloom Burton rating of Medicenna Therapeutics (TSE:MDNA) on 8/16/2022
MDNA Medicenna Therapeutics	C$1.55 +1.3%	7/28/2022	Reiterated by	Bloom Burton	-	Buy	C$11.00	N/A	View details for Bloom Burton rating of Medicenna Therapeutics (TSE:MDNA) on 7/28/2022
HLS HLS Therapeutics	C$4.75 -4.0%	7/26/2022	Reiterated by	Bloom Burton	-	Buy	C$22.00	N/A	View details for Bloom Burton rating of HLS Therapeutics (TSE:HLS) on 7/26/2022
MBX Microbix Biosystems	C$0.34 -1.5%	6/6/2022	Reiterated by	Bloom Burton	Analyst A. Borovina	Buy		N/A	View details for Bloom Burton rating of Microbix Biosystems (TSE:MBX) on 6/6/2022
GUD Knight Therapeutics	C$5.82 +0.5%	3/28/2022	Reiterated by	Bloom Burton	Analyst D. Martin	Buy	C$6.70	N/A	View details for Bloom Burton rating of Knight Therapeutics (TSE:GUD) on 3/28/2022
GUD Knight Therapeutics	C$5.82 +0.5%	3/25/2022	Downgraded by	Bloom Burton	Analyst D. Martin	Buy -> Accumulate		N/A	View details for Bloom Burton rating of Knight Therapeutics (TSE:GUD) on 3/25/2022
RX BioSyent	C$8.40	3/10/2022	Upgraded by	Bloom Burton	Analyst D. Martin	Hold -> Accumulate		N/A	View details for Bloom Burton rating of BioSyent (CVE:RX) on 3/10/2022
DOC CloudMD Software & Services	C$0.09	12/22/2021	Reiterated by	Bloom Burton	Analyst P. Pandurangan	Buy		N/A	View details for Bloom Burton rating of CloudMD Software & Services (CVE:DOC) on 12/22/2021
ABCL AbCellera Biologics	$3.97 -1.0%	12/19/2021	Reiterated by	Bloom Burton	Analyst A. Borovina	Buy		Low	View details for Bloom Burton rating of AbCellera Biologics (NASDAQ:ABCL) on 12/19/2021
AUPH Aurinia Pharmaceuticals	$5.09 +0.8%	10/1/2021	Initiated by	Bloom Burton	Analyst Prasath Pandurangan	Hold	$23.00	Medium	View details for Bloom Burton rating of Aurinia Pharmaceuticals (NASDAQ:AUPH) on 10/1/2021
RPTX Repare Therapeutics	$3.36 +3.1%	9/30/2021	Initiated by	Bloom Burton	Analyst Prasath Pandurangan	Buy	$49.00	Low	View details for Bloom Burton rating of Repare Therapeutics (NASDAQ:RPTX) on 9/30/2021
MDNA Medicenna Therapeutics	C$1.55 +1.3%	9/22/2021	Initiated by	Bloom Burton	Analyst Prasath Pandurangan	Buy	C$11.00	N/A	View details for Bloom Burton rating of Medicenna Therapeutics (TSE:MDNA) on 9/22/2021
BLU BELLUS Health	C$19.48 -0.1%	8/13/2021	Reiterated by	Bloom Burton	Analyst D. Martin	Buy		N/A	View details for Bloom Burton rating of BELLUS Health (TSE:BLU) on 8/13/2021
HLS HLS Therapeutics	C$4.75 -4.0%	8/5/2021	Reiterated by	Bloom Burton	Analyst D. Martin	Buy		N/A	View details for Bloom Burton rating of HLS Therapeutics (TSE:HLS) on 8/5/2021
VMD Viemed Healthcare	$8.06 +2.8%	8/4/2021	Upgraded by	Bloom Burton	Analyst P. Pandurangan	Accumulate -> Buy		Low	View details for Bloom Burton rating of Viemed Healthcare (NASDAQ:VMD) on 8/4/2021
VMD Viemed Healthcare	C$10.45 +2.9%	8/4/2021	Upgraded by	Bloom Burton	Analyst P. Pandurangan	Accumulate -> Buy		N/A	View details for Bloom Burton rating of Viemed Healthcare (TSE:VMD) on 8/4/2021
AUPH Aurinia Pharmaceuticals	$5.09 +0.8%	5/7/2021	Upgraded by	Bloom Burton	Analyst D. Martin	Accumulate -> Buy		High	View details for Bloom Burton rating of Aurinia Pharmaceuticals (NASDAQ:AUPH) on 5/7/2021
GUD Knight Therapeutics	C$5.82 +0.5%	3/26/2021	Upgraded by	Bloom Burton	Analyst D. Martin	Accumulate -> Buy		N/A	View details for Bloom Burton rating of Knight Therapeutics (TSE:GUD) on 3/26/2021
RX BioSyent	C$8.40	3/18/2021	Downgraded by	Bloom Burton	Analyst D. Martin	Accumulate -> Hold		N/A	View details for Bloom Burton rating of BioSyent (CVE:RX) on 3/18/2021
MDP Medexus Pharmaceuticals	C$7.75 -4.9%	2/23/2021	Upgraded by	Bloom Burton	Analyst D. Martin	Accumulate -> Buy		N/A	View details for Bloom Burton rating of Medexus Pharmaceuticals (CVE:MDP) on 2/23/2021
EPIX ESSA Pharma	$6.40	2/12/2021	Reiterated by	Bloom Burton	Analyst D. Martin	Buy		N/A	View details for Bloom Burton rating of ESSA Pharma (NASDAQ:EPIX) on 2/12/2021
CRHM CRH Medical	$3.99	1/8/2021	Downgraded by	Bloom Burton	Analyst D. Martin	Hold	$3.00	N/A	View details for Bloom Burton rating of CRH Medical (NYSEAMERICAN:CRHM) on 1/8/2021
CRHM CRH Medical	$3.99	12/23/2020	Downgraded by	Bloom Burton	Analyst D. Martin	Buy -> Hold		N/A	View details for Bloom Burton rating of CRH Medical (NYSEAMERICAN:CRHM) on 12/23/2020
FUSN Fusion Pharmaceuticals	$21.42 +0.5%	12/17/2020	Reiterated by	Bloom Burton	Analyst A. Borovina	Buy		Medium	View details for Bloom Burton rating of Fusion Pharmaceuticals (NASDAQ:FUSN) on 12/17/2020
MRVFF Nuvo Pharmaceuticals	$0.98	11/17/2020	Reiterated by	Bloom Burton	Analyst D. Martin	Buy		N/A	View details for Bloom Burton rating of Nuvo Pharmaceuticals (OTCMKTS:MRVFF) on 11/17/2020
AUPH Aurinia Pharmaceuticals	$5.09 +0.8%	11/3/2020	Downgraded by	Bloom Burton	Analyst D. Martin	Buy -> Accumulate		Low	View details for Bloom Burton rating of Aurinia Pharmaceuticals (NASDAQ:AUPH) on 11/3/2020
VMD Viemed Healthcare	$8.06 +2.8%	10/19/2020	Reiterated by	Bloom Burton	Analyst P. Pandurangan	Accumulate		High	View details for Bloom Burton rating of Viemed Healthcare (NASDAQ:VMD) on 10/19/2020
VMD Viemed Healthcare	C$10.45 +2.9%	10/19/2020	Reiterated by	Bloom Burton	Analyst P. Pandurangan	Accumulate		N/A	View details for Bloom Burton rating of Viemed Healthcare (TSE:VMD) on 10/19/2020
RPTX Repare Therapeutics	$3.36 +3.1%	9/17/2020	Reiterated by	Bloom Burton	Analyst D. Martin	Buy		High	View details for Bloom Burton rating of Repare Therapeutics (NASDAQ:RPTX) on 9/17/2020
Don’t Miss Out on the AI Gold Rush That’s Just Getting Started (Ad) “Titan of Tech” Bets Big on Tiny AI Company He’s made as much as 3,250,000% in just three years on companies like Facebook, Airbnb, and PayPal… But our research shows his latest investment could be his most successful venture yet. See how you can invest alongside him
HTL Hamilton Thorne	C$1.45 +4.3%	8/21/2020	Reiterated by	Bloom Burton	Analyst D. Martin	Buy		N/A	View details for Bloom Burton rating of Hamilton Thorne (CVE:HTL) on 8/21/2020
XENE Xenon Pharmaceuticals	$41.09 +2.7%	8/13/2020	Reiterated by	Bloom Burton	Analyst D. Martin	Buy	$25.00	Medium	View details for Bloom Burton rating of Xenon Pharmaceuticals (NASDAQ:XENE) on 8/13/2020
CRH CRH	$78.79 +1.5%	8/14/2020	Reiterated by	Bloom Burton	-	Buy		Low	View details for Bloom Burton rating of CRH (NYSE:CRH) on 8/14/2020
CRHM CRH Medical	$3.99	8/13/2020	Reiterated by	Bloom Burton	Analyst D. Martin	Buy	$4.00	N/A	View details for Bloom Burton rating of CRH Medical (NYSEAMERICAN:CRHM) on 8/13/2020
CRHM CRH Medical	$3.99	8/12/2020	Reiterated by	Bloom Burton	Analyst D. Martin	Buy		High	View details for Bloom Burton rating of CRH Medical (NYSEAMERICAN:CRHM) on 8/12/2020
HLS HLS Therapeutics	C$4.75 -4.0%	7/21/2020	Upgraded by	Bloom Burton	Analyst D. Martin	Accumulate -> Buy		N/A	View details for Bloom Burton rating of HLS Therapeutics (TSE:HLS) on 7/21/2020
GUD Knight Therapeutics	C$5.82 +0.5%	6/29/2020	Downgraded by	Bloom Burton	Analyst D. Martin	Buy -> Accumulate		N/A	View details for Bloom Burton rating of Knight Therapeutics (TSE:GUD) on 6/29/2020
ZYME Zymeworks	$8.56 -1.7%	6/14/2020	Reiterated by	Bloom Burton	Analyst D. Martin	Buy		Low	View details for Bloom Burton rating of Zymeworks (NYSE:ZYME) on 6/14/2020
EPIX ESSA Pharma	$6.40	5/24/2020	Reiterated by	Bloom Burton	-	Buy	$9.00	High	View details for Bloom Burton rating of ESSA Pharma (NASDAQ:EPIX) on 5/24/2020
CPH Cipher Pharmaceuticals	C$8.81 +5.0%	5/8/2020	Upgraded by	Bloom Burton	Analyst D. Martin	Hold -> Accumulate		N/A	View details for Bloom Burton rating of Cipher Pharmaceuticals (TSE:CPH) on 5/8/2020
HLS HLS Therapeutics	C$4.75 -4.0%	3/31/2020	Downgraded by	Bloom Burton	Analyst D. Martin	Buy -> Accumulate		N/A	View details for Bloom Burton rating of HLS Therapeutics (TSE:HLS) on 3/31/2020
RX BioSyent	C$8.40	3/19/2020	Downgraded by	Bloom Burton	Analyst D. Martin	Buy -> Accumulate		N/A	View details for Bloom Burton rating of BioSyent (CVE:RX) on 3/19/2020
AUPH Aurinia Pharmaceuticals	$5.09 +0.8%	3/19/2020	Reiterated by	Bloom Burton	Analyst D. Martin	Buy	$23.00	Low	View details for Bloom Burton rating of Aurinia Pharmaceuticals (NASDAQ:AUPH) on 3/19/2020
MRVFF Nuvo Pharmaceuticals	$0.98	11/12/2019	Upgraded by	Bloom Burton	Analyst D. Martin	Hold -> Buy		N/A	View details for Bloom Burton rating of Nuvo Pharmaceuticals (OTCMKTS:MRVFF) on 11/12/2019
GUD Knight Therapeutics	C$5.82 +0.5%	10/22/2019	Upgraded by	Bloom Burton	Analyst D. Martin	Accumulate -> Buy		N/A	View details for Bloom Burton rating of Knight Therapeutics (TSE:GUD) on 10/22/2019
HLS HLS Therapeutics	C$4.75 -4.0%	10/4/2019	Upgraded by	Bloom Burton	Analyst D. Martin	Hold -> Buy		N/A	View details for Bloom Burton rating of HLS Therapeutics (TSE:HLS) on 10/4/2019
AUPH Aurinia Pharmaceuticals	$5.09 +0.8%	10/2/2019	Reiterated by	Bloom Burton	Analyst D. Martin	Buy		Low	View details for Bloom Burton rating of Aurinia Pharmaceuticals (NASDAQ:AUPH) on 10/2/2019
RX BioSyent	C$8.40	8/26/2019	Upgraded by	Bloom Burton	Analyst D. Martin	Accumulate -> Buy		N/A	View details for Bloom Burton rating of BioSyent (CVE:RX) on 8/26/2019
CPH Cipher Pharmaceuticals	C$8.81 +5.0%	8/12/2019	Reiterated by	Bloom Burton	Analyst D. Martin	Hold		N/A	View details for Bloom Burton rating of Cipher Pharmaceuticals (TSE:CPH) on 8/12/2019
HLS HLS Therapeutics	C$4.75 -4.0%	8/9/2019	Downgraded by	Bloom Burton	Analyst D. Martin	Buy -> Hold		N/A	View details for Bloom Burton rating of HLS Therapeutics (TSE:HLS) on 8/9/2019
CRHM CRH Medical	$3.99	8/1/2019	Upgraded by	Bloom Burton	Analyst D. Martin	Accumulate -> Buy		N/A	View details for Bloom Burton rating of CRH Medical (NYSEAMERICAN:CRHM) on 8/1/2019
BLU BELLUS Health	C$19.48 -0.1%	8/1/2019	Reiterated by	Bloom Burton	Analyst D. Martin	Buy		N/A	View details for Bloom Burton rating of BELLUS Health (TSE:BLU) on 8/1/2019
MDP Medexus Pharmaceuticals	C$7.75 -4.9%	7/3/2019	Reiterated by	Bloom Burton	Analyst D. Martin	Accumulate		N/A	View details for Bloom Burton rating of Medexus Pharmaceuticals (CVE:MDP) on 7/3/2019
MRVFF Nuvo Pharmaceuticals	$0.98	5/16/2019	Downgraded by	Bloom Burton	Analyst D. Martin	Buy -> Hold		N/A	View details for Bloom Burton rating of Nuvo Pharmaceuticals (OTCMKTS:MRVFF) on 5/16/2019
MRVFF Nuvo Pharmaceuticals	$0.98	4/1/2019	Reiterated by	Bloom Burton	Analyst D. Martin	Buy		N/A	View details for Bloom Burton rating of Nuvo Pharmaceuticals (OTCMKTS:MRVFF) on 4/1/2019
HLS HLS Therapeutics	C$4.75 -4.0%	3/22/2019	Reiterated by	Bloom Burton	Analyst D. Martin	Buy		N/A	View details for Bloom Burton rating of HLS Therapeutics (TSE:HLS) on 3/22/2019
CPH Cipher Pharmaceuticals	C$8.81 +5.0%	3/20/2019	Reiterated by	Bloom Burton	Analyst D. Martin	Buy		N/A	View details for Bloom Burton rating of Cipher Pharmaceuticals (TSE:CPH) on 3/20/2019
CXRXF ADVANZ PHARMA	$17.06	3/15/2019	Reiterated by	Bloom Burton	Analyst D. Martin	Hold		Low	View details for Bloom Burton rating of ADVANZ PHARMA (OTCMKTS:CXRXF) on 3/15/2019
GUD Knight Therapeutics	C$5.82 +0.5%	11/9/2018	Reiterated by	Bloom Burton	Analyst D. Martin	Accumulate		N/A	View details for Bloom Burton rating of Knight Therapeutics (TSE:GUD) on 11/9/2018
BLU BELLUS Health	C$19.48 -0.1%	7/6/2018	Reiterated by	Bloom Burton	Analyst D. Martin	Buy		N/A	View details for Bloom Burton rating of BELLUS Health (TSE:BLU) on 7/6/2018
MRVFF Nuvo Pharmaceuticals	$0.98	3/26/2018	Upgraded by	Bloom Burton	Analyst D. Martin	Accumulate -> Buy		N/A	View details for Bloom Burton rating of Nuvo Pharmaceuticals (OTCMKTS:MRVFF) on 3/26/2018
RX BioSyent	C$8.40	3/22/2018	Reiterated by	Bloom Burton	Analyst D. Martin	Accumulate		N/A	View details for Bloom Burton rating of BioSyent (CVE:RX) on 3/22/2018
EPI ESSA Pharma	C$8.20 +7.2%	1/18/2018	Upgraded by	Bloom Burton	Analyst D. Martin	Hold -> Buy		N/A	View details for Bloom Burton rating of ESSA Pharma (CVE:EPI) on 1/18/2018
EPIX ESSA Pharma	$6.40	1/18/2018	Upgraded by	Bloom Burton	Analyst D. Martin	Hold -> Buy		High	View details for Bloom Burton rating of ESSA Pharma (NASDAQ:EPIX) on 1/18/2018
MRVFF Nuvo Pharmaceuticals	$0.98	11/3/2017	Downgraded by	Bloom Burton	Analyst D. Martin	Buy -> Accumulate		N/A	View details for Bloom Burton rating of Nuvo Pharmaceuticals (OTCMKTS:MRVFF) on 11/3/2017
HTL Hamilton Thorne	C$1.45 +4.3%	10/25/2017	Reiterated by	Bloom Burton	Analyst D. Martin	Buy		N/A	View details for Bloom Burton rating of Hamilton Thorne (CVE:HTL) on 10/25/2017
EPIX ESSA Pharma	$6.40	9/12/2017	Downgraded by	Bloom Burton	Analyst D. Martin	Buy -> Hold		Low	View details for Bloom Burton rating of ESSA Pharma (NASDAQ:EPIX) on 9/12/2017
CPH Cipher Pharmaceuticals	C$8.81 +5.0%	8/14/2017	Downgraded by	Bloom Burton	Analyst D. Martin	Buy -> Hold		N/A	View details for Bloom Burton rating of Cipher Pharmaceuticals (TSE:CPH) on 8/14/2017
CRHM CRH Medical	$3.99	7/14/2017	Downgraded by	Bloom Burton	Analyst D. Martin	Buy -> Accumulate		N/A	View details for Bloom Burton rating of CRH Medical (NYSEAMERICAN:CRHM) on 7/14/2017
EPIX ESSA Pharma	$6.40	5/18/2017	Reiterated by	Bloom Burton	Analyst D. Martin	Buy		Low	View details for Bloom Burton rating of ESSA Pharma (NASDAQ:EPIX) on 5/18/2017
MRVFF Nuvo Pharmaceuticals	$0.98	5/15/2017	Upgraded by	Bloom Burton	Analyst D. Martin	Hold -> Buy		N/A	View details for Bloom Burton rating of Nuvo Pharmaceuticals (OTCMKTS:MRVFF) on 5/15/2017
CPH Cipher Pharmaceuticals	C$8.81 +5.0%	5/12/2017	Upgraded by	Bloom Burton	Analyst D. Martin	Hold -> Buy		N/A	View details for Bloom Burton rating of Cipher Pharmaceuticals (TSE:CPH) on 5/12/2017
MRVFF Nuvo Pharmaceuticals	$0.98	5/9/2017	Downgraded by	Bloom Burton	Analyst D. Martin	Accumulate -> Hold		N/A	View details for Bloom Burton rating of Nuvo Pharmaceuticals (OTCMKTS:MRVFF) on 5/9/2017
BLU BELLUS Health	C$19.48 -0.1%	3/1/2017	Reiterated by	Bloom Burton	Analyst D. Martin	Buy		N/A	View details for Bloom Burton rating of BELLUS Health (TSE:BLU) on 3/1/2017
CRHM CRH Medical	$3.99	2/24/2017	Downgraded by	Bloom Burton	Analyst D. Martin	Buy -> Accumulate		N/A	View details for Bloom Burton rating of CRH Medical (NYSEAMERICAN:CRHM) on 2/24/2017
RX BioSyent	C$8.40	2/13/2017	Reiterated by	Bloom Burton	Analyst D. Martin	Accumulate		N/A	View details for Bloom Burton rating of BioSyent (CVE:RX) on 2/13/2017
CPH Cipher Pharmaceuticals	C$8.81 +5.0%	2/13/2017	Reiterated by	Bloom Burton	Analyst D. Martin	Hold		N/A	View details for Bloom Burton rating of Cipher Pharmaceuticals (TSE:CPH) on 2/13/2017
ABUS Arbutus Biopharma	$2.75 +4.2%	1/9/2017	Upgraded by	Bloom Burton	Analyst D. Martin	Accumulate -> Buy		N/A	View details for Bloom Burton rating of Arbutus Biopharma (NASDAQ:ABUS) on 1/9/2017
XENE Xenon Pharmaceuticals	$41.09 +2.7%	12/22/2016	Initiated by	Bloom Burton	-	Buy	$14.50	N/A	View details for Bloom Burton rating of Xenon Pharmaceuticals (NASDAQ:XENE) on 12/22/2016
ABUS Arbutus Biopharma	$2.75 +4.2%	12/14/2016	Reiterated by	Bloom Burton	Analyst D. Martin	Accumulate		N/A	View details for Bloom Burton rating of Arbutus Biopharma (NASDAQ:ABUS) on 12/14/2016
Don’t Miss Out on the AI Gold Rush That’s Just Getting Started (Ad) “Titan of Tech” Bets Big on Tiny AI Company He’s made as much as 3,250,000% in just three years on companies like Facebook, Airbnb, and PayPal… But our research shows his latest investment could be his most successful venture yet. See how you can invest alongside him
GUD Knight Therapeutics	C$5.82 +0.5%	11/10/2016	Reiterated by	Bloom Burton	Analyst D. Martin	Accumulate		N/A	View details for Bloom Burton rating of Knight Therapeutics (TSE:GUD) on 11/10/2016
AUPH Aurinia Pharmaceuticals	$5.09 +0.8%	11/4/2016	Reiterated by	Bloom Burton	Analyst D. Martin	Buy		N/A	View details for Bloom Burton rating of Aurinia Pharmaceuticals (NASDAQ:AUPH) on 11/4/2016
MRVFF Nuvo Pharmaceuticals	$0.98	11/2/2016	Reiterated by	Bloom Burton	Analyst D. Martin	Accumulate		N/A	View details for Bloom Burton rating of Nuvo Pharmaceuticals (OTCMKTS:MRVFF) on 11/2/2016
CRHM CRH Medical	$3.99	10/28/2016	Reiterated by	Bloom Burton	Analyst D. Martin	Buy		N/A	View details for Bloom Burton rating of CRH Medical (NYSEAMERICAN:CRHM) on 10/28/2016
ACHV Achieve Life Sciences	$4.50 +2.0%	5/3/2013	Target Raised by	Bloom Burton	-	Buy	$4,000.00 -> $5,000.00	N/A	View details for Bloom Burton rating of Achieve Life Sciences (NASDAQ:ACHV) on 5/3/2013
ACHV Achieve Life Sciences	$4.50 +2.0%	3/8/2013	Target Raised by	Bloom Burton	-		$3,600.00 -> $4,000.00	N/A	View details for Bloom Burton rating of Achieve Life Sciences (NASDAQ:ACHV) on 3/8/2013
ONC Oncolytics Biotech	C$1.43 -2.1%	12/18/2012	Downgraded by	Bloom Burton	-	Buy -> Hold		N/A	View details for Bloom Burton rating of Oncolytics Biotech (TSE:ONC) on 12/18/2012
THTX Theratechnologies	$1.38 +3.0%	6/25/2012	Downgraded by	Bloom Burton	-	Hold -> Sell	$2.50 -> $0.75	N/A	View details for Bloom Burton rating of Theratechnologies (NASDAQ:THTX) on 6/25/2012
ACHV Achieve Life Sciences	$4.50 +2.0%	5/4/2012	Target Lowered by	Bloom Burton	-	Buy	$3,800.00 -> $3,600.00	N/A	View details for Bloom Burton rating of Achieve Life Sciences (NASDAQ:ACHV) on 5/4/2012

MarketBeat Community Rating for Bloom Burton

Community Ranking:		2.7 out of 5 ( 2.7 of 5 stars)
Outperform Votes:		24,036 (Vote Outperform)
Underperform Votes:		20,772 (Vote Underperform)
Total Votes:		44,808

MarketBeat's community ratings are surveys of what our community members think about Bloom Burton and other research firms. Vote "Outperform" if you believe Bloom Burton's recommendations will outperform the S&P 500 over the long term. Vote "Underperform" if you believe Bloom Burton's recommendations will underperform the S&P 500 over the long term. You may vote once every thirty days.

Stock Ratings Reports and Tools

Today's Ratings:

Top Rated Stocks:

More Ratings Tools:

Ratings for Popular Stocks:

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial

Bloom Burton Analyst Recommendations & Stock Picks

MarketBeat Community Rating for Bloom Burton

Stock Ratings Reports and Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info